Geron (GERN) Interest Coverage Ratio Growth (3y) (2013 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Interest Cover Growth (3y) (Qtr)
1 Quantum Biopharma 1,638,563.89 Bn 1,638,563.89 Bn - 79.36%
2 Alterity Therapeutics 767,934.24 Bn 767,934.20 Bn - -
3 Legend Biotech 2,937.00 Bn 2,936.10 Bn 242.10 Mn 29.25%
4 Nanobiotix 2,282.79 Bn 2,282.72 Bn - -
5 Akari Therapeutics 2,169.69 Bn 2,169.69 Bn - -
6 Vertex Pharmaceuticals 110.41 Bn 103.16 Bn 2.59 Bn -
7 Regeneron Pharmaceuticals 66.44 Bn 57.69 Bn 3.31 Bn -1.78%
8 Evaxion A 65.44 Bn 65.42 Bn - -16.86%
9 Alnylam Pharmaceuticals 39.53 Bn 36.52 Bn 959.66 Mn 40.09%
10 Geron 856,799.98 856,799.98 - 26.01%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 26.01%
Dec 31, 2025 44.90%
Sep 30, 2025 58.19%
Jun 30, 2025 56.44%
Mar 31, 2025 52.81%
Dec 31, 2024 56.14%
Sep 30, 2024 27.46%
Jun 30, 2024 16.54%
Mar 31, 2024 24.70%
Dec 31, 2023 8.82%
Sep 30, 2023 80.95%
Mar 31, 2023 62.11%
Dec 31, 2022 -26.18%
Sep 30, 2022 63.96%
Jun 30, 2022 67.33%
Mar 31, 2022 68.63%
Dec 31, 2021 61.53%
Sep 30, 2021 41.20%
Jun 30, 2021 33.60%
Mar 31, 2021 54.74%
Dec 31, 2020 58.53%
Sep 30, 2020 -102.38%
Mar 31, 2020 -2.42%
Dec 31, 2019 98.18%
Sep 30, 2019 -36.52%
Jun 30, 2019 -2.66%
Mar 31, 2019 -13.25%
Dec 31, 2018 -3.52%
Sep 30, 2018 -28.00%
Jun 30, 2018 34.20%
Mar 31, 2018 -1.60%
Dec 31, 2017 -0.27%
Sep 30, 2017 3.68%
Jun 30, 2017 3.68%
Mar 31, 2017 13.20%
Dec 31, 2016 19.77%
Sep 30, 2016 36.70%
Jun 30, 2016 9.86%
Mar 31, 2016 13.41%
Dec 31, 2015 25.06%
Sep 30, 2015 148.28%
Jun 30, 2015 22.45%
Mar 31, 2015 21.76%
Dec 31, 2014 5.93%
Sep 30, 2014 -37.07%
Jun 30, 2014 18.31%
Mar 31, 2014 9.58%
Dec 31, 2013 -8.31%
Sep 30, 2013 -59.78%
Jun 30, 2013 1.74%